As of 12:31 PM on the 26th, Myungmoon Pharmaceutical is trading at 7,100 KRW, up 4.72% from the previous day. This marks a 44.02% increase compared to April 29. Myungmoon Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.
Today, foreigners are tentatively recorded as net sellers of 13,000 shares. Over the past 5 days, individual investors have net purchased 136,612 shares, while foreigners and institutions have net sold 124,017 shares and 28,767 shares, respectively.
On May 18, Myungmoon Pharmaceutical became a market topic with the headline "Despite Operating Loss, Turning to an Uptrend... Expectations for COVID-19 Treatment."

[Table] Net Trading Volume of Foreigners and Institutions (Unit: Shares)

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
